About this trial
This Type 1 hybrid effectiveness-implementation randomized controlled trial, Remote Fentanyl Test Strip Distribution and Education to Prevent Drug Overdose, aims to address the United States opioid crisis driven by fentanyl and other synthetic opioids by reducing overdose rates. It is supported by and included in the HEAL Initiative. This study would be the first national, fully remote trial to assess the impact of fentanyl test strips on overdose outcomes, using a novel 2x2 design crossing fentanyl test strip distribution and education to determine which approach most significantly reduces overdose rates while minimizing costs. This research will inform scalability around mail-based fentanyl test strip distribution and education programs to address the nation's opioid overdose crisis.
Eligibility criteria
Qualifiers
18 years old
English-speaking and reading
Report using illicit opioids and/or stimulants (including counterfeit pills) within the past 3 months per the ASSIST
Able and willing to provide informed consent
Disqualifiers
Living in a restricted environment (e.g., prison)
Trial design
Treatments tested in this trial
- Fentanyl test strips
- Fentanyl test strip education
Treatment groups
Sponsors and collaborators
University of Alabama at Birmingham
Lead sponsor
National Institute on Drug Abuse (NIDA)
Collaborator